title: Should intravenous iron be upfront therapy for iron deficiency anemia?
authors.affiliation: Auerbach Hematology and Oncology, Baltimore, Maryland 21234, USA. mauerbachmd@aol.com
authors.forename: Michael
authors.initials: M
authors.lastname: Auerbach
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D002648:Child; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid; D006397:Hematinics / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D007505:Iron-Dextran Complex / Q000008:administration & dosage / Q000009:adverse effects; D008970:Molecular Weight
chemical_list: D005290:Ferric Compounds; D006397:Hematinics; D007505:Iron-Dextran Complex; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid